These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
36 related articles for article (PubMed ID: 10090404)
1. Involvement of receptor-bound protein methyltransferase PRMT1 in antiviral and antiproliferative effects of type I interferons. Altschuler L; Wook JO; Gurari D; Chebath J; Revel M J Interferon Cytokine Res; 1999 Feb; 19(2):189-95. PubMed ID: 10090404 [TBL] [Abstract][Full Text] [Related]
2. A protein-arginine methyltransferase binds to the intracytoplasmic domain of the IFNAR1 chain in the type I interferon receptor. Abramovich C; Yakobson B; Chebath J; Revel M EMBO J; 1997 Jan; 16(2):260-6. PubMed ID: 9029147 [TBL] [Abstract][Full Text] [Related]
3. A dominant negative mutant of an IFN regulatory factor family protein inhibits both type I and type II IFN-stimulated gene expression and antiproliferative activity of IFNs. Thornton AM; Ogryzko VV; Dent A; Sharf R; Levi BZ; Kanno Y; Staudt LM; Howard BH; Ozato K J Immunol; 1996 Dec; 157(11):5145-54. PubMed ID: 8943426 [TBL] [Abstract][Full Text] [Related]
5. High resistance of human parainfluenza type 2 virus protein-expressing cells to the antiviral and anti-cell proliferative activities of alpha/beta interferons: cysteine-rich V-specific domain is required for high resistance to the interferons. Nishio M; Tsurudome M; Ito M; Kawano M; Komada H; Ito Y J Virol; 2001 Oct; 75(19):9165-76. PubMed ID: 11533180 [TBL] [Abstract][Full Text] [Related]
6. A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities. Ozes ON; Reiter Z; Klein S; Blatt LM; Taylor MW J Interferon Res; 1992 Feb; 12(1):55-9. PubMed ID: 1573283 [TBL] [Abstract][Full Text] [Related]
7. Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus. Anderson SL; Carton JM; Lou J; Xing L; Rubin BY Virology; 1999 Mar; 256(1):8-14. PubMed ID: 10087221 [TBL] [Abstract][Full Text] [Related]
8. Effect of human fibroblast interferon on the antiviral activity of mammalian cells treated with bleomycin, vincristine, or mitomycin C. Suhadolnik RJ; Sawada Y; Flick MB; Reichenbach NL; Mosca JD Cancer Res; 1983 Nov; 43(11):5462-6. PubMed ID: 6193871 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of 2-5A synthetase expression by antisense RNA interferes with interferon-mediated antiviral and antiproliferative effects and induces anchorage-independent cell growth. Yaffe A; Schwarz Y; Hacohen D; Kinar Y; Nir U; Salzberg S Cell Growth Differ; 1996 Aug; 7(8):969-78. PubMed ID: 8853892 [TBL] [Abstract][Full Text] [Related]
10. The antiproliferative and antiviral activities of IFN-tau variants in human cells. Alexenko AP; Leaman DW; Li J; Roberts RM J Interferon Cytokine Res; 1997 Dec; 17(12):769-79. PubMed ID: 9452365 [TBL] [Abstract][Full Text] [Related]
11. [Antiviral and antiproliferative activity of human interferons and their induction of 2',5'-oligoadenylate synthetase]. Krispin TI; Itkes AV; Balandin IG; Solov'eva MF; Kuznetsov VP Mol Gen Mikrobiol Virusol; 1986 Apr; (4):42-6. PubMed ID: 2432419 [TBL] [Abstract][Full Text] [Related]
13. Down-regulation of type I interferon receptor sensitizes bladder cancer cells to vesicular stomatitis virus-induced cell death. Zhang KX; Matsui Y; Hadaschik BA; Lee C; Jia W; Bell JC; Fazli L; So AI; Rennie PS Int J Cancer; 2010 Aug; 127(4):830-8. PubMed ID: 19957332 [TBL] [Abstract][Full Text] [Related]
14. The comparative anti-herpes simplex virus effects of human interferons. Taylor JL; Little SD; O'Brien WJ J Interferon Cytokine Res; 1998 Mar; 18(3):159-65. PubMed ID: 9555977 [TBL] [Abstract][Full Text] [Related]
15. Angiodysplasia in embryo lacking protein arginine methyltransferase 1 in vascular endothelial cells. Ishimaru T; Ishida J; Kim JD; Mizukami H; Hara K; Hashimoto M; Yagami KI; Sugiyama F; Fukamizu A J Biochem; 2017 Mar; 161(3):255-258. PubMed ID: 28003433 [TBL] [Abstract][Full Text] [Related]
16. Therapy-induced antibodies against the antiviral and antiproliferative effects of interferons in patients with chronic hepatitis C virus infection. Bálint E; Bakay M; Onody K; Farkas F; Horváth G; Tolvaj G; Dávid K; Horányi M; Béládi I Acta Microbiol Immunol Hung; 2004; 51(3):359-69. PubMed ID: 15571075 [TBL] [Abstract][Full Text] [Related]
17. Protein arginine methylation: an emerging regulator of the cell cycle. Raposo AE; Piller SC Cell Div; 2018; 13():3. PubMed ID: 29568320 [TBL] [Abstract][Full Text] [Related]
18. Global functional profiling of human ubiquitome identifies E3 ubiquitin ligase DCST1 as a novel negative regulator of Type-I interferon signaling. Nair S; Bist P; Dikshit N; Krishnan MN Sci Rep; 2016 Oct; 6():36179. PubMed ID: 27782195 [TBL] [Abstract][Full Text] [Related]
19. Ligand-independent interaction of the type I interferon receptor complex is necessary to observe its biological activity. Krause CD; Digioia G; Izotova LS; Xie J; Kim Y; Schwartz BJ; Mirochnitchenko OV; Pestka S Cytokine; 2013 Oct; 64(1):286-97. PubMed ID: 23830819 [TBL] [Abstract][Full Text] [Related]
20. A transient kinetic analysis of PRMT1 catalysis. Feng Y; Xie N; Jin M; Stahley MR; Stivers JT; Zheng YG Biochemistry; 2011 Aug; 50(32):7033-44. PubMed ID: 21736313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]